BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Olivera-Severo D, Uberti AF, Marques MS, Pinto MT, Gomez-Lazaro M, Figueiredo C, Leite M, Carlini CR. A New Role for Helicobacter pylori Urease: Contributions to Angiogenesis. Front Microbiol 2017;8:1883. [PMID: 29021786 DOI: 10.3389/fmicb.2017.01883] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Patrad E, Khalighfard S, Amiriani T, Khori V, Alizadeh AM. Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy. Cell Oncol (Dordr) 2022. [PMID: 36149600 DOI: 10.1007/s13402-022-00715-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Moran TE, Hammers DE, Lee SW. The Role of Host-Cellular Responses in COVID-19 Endothelial Dysfunction. Curr Drug Targets 2022;23:1555-66. [PMID: 35748550 DOI: 10.2174/1389450123666220624094940] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Salinas Ibáñez ÁG, Origone AL, Liggieri CS, Barberis SE, Vega AE. Asclepain cI, a proteolytic enzyme from Asclepias curassavica L., a south American plant, against Helicobacter pylori. Front Microbiol 2022;13:961958. [DOI: 10.3389/fmicb.2022.961958] [Reference Citation Analysis]
4 Rostami H, Haddadi MH. Benzimidazole derivatives: A versatile scaffold for drug development against Helicobacter pylori ‐related diseases. Fundamemntal Clinical Pharma 2022. [DOI: 10.1111/fcp.12810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 He J, Hu W, Ouyang Q, Zhang S, He L, Chen W, Li X, Hu C. Helicobacter pylori infection induces stem cell-like properties in Correa cascade of gastric cancer. Cancer Lett 2022;:215764. [PMID: 35654291 DOI: 10.1016/j.canlet.2022.215764] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Sijmons D, Guy AJ, Walduck AK, Ramsland PA. Helicobacter pylori and the Role of Lipopolysaccharide Variation in Innate Immune Evasion. Front Immunol 2022;13:868225. [DOI: 10.3389/fimmu.2022.868225] [Reference Citation Analysis]
7 Sánchez-alonzo K, Arellano-arriagada L, Bernasconi H, Parra-sepúlveda C, Campos VL, Silva-mieres F, Sáez-carrillo K, Smith CT, García-cancino A. An Anaerobic Environment Drives the Harboring of Helicobacter pylori within Candida Yeast Cells. Biology 2022;11:738. [DOI: 10.3390/biology11050738] [Reference Citation Analysis]
8 Khan M, Shamim S. Anisi Stellati Fructus, a Significant Traditional Chinese Medicine (TCM) Herb and Its Bioactivity against Gastric Cancer. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-14. [DOI: 10.1155/2022/4071489] [Reference Citation Analysis]
9 Boumi S, Talebi M, Sarmad Y, Bassam K, Barzegar M, Hosseini FS, Amini M, Amanlou M. Synthesis, Molecular Docking and Biological Evaluation of Diaryl Pyrimidine Derivatives as Urease Inhibitors. Pharm Chem J. [DOI: 10.1007/s11094-022-02582-6] [Reference Citation Analysis]
10 Sohrabi M, Nazari Montazer M, Farid SM, Tanideh N, Dianatpour M, Moazzam A, Zomorodian K, Yazdanpanah S, Asadi M, Hosseini S, Biglar M, Larijani B, Amanlou M, Barazandeh Tehrani M, Iraji A, Mahdavi M. Design and synthesis of novel nitrothiazolacetamide conjugated to different thioquinazolinone derivatives as anti-urease agents. Sci Rep 2022;12:2003. [PMID: 35132095 DOI: 10.1038/s41598-022-05736-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
11 Capparelli R, Iannelli D. Epigenetics and Helicobacter pylori. Int J Mol Sci 2022;23:1759. [PMID: 35163679 DOI: 10.3390/ijms23031759] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Salinas Ibáñez ÁG, Vallés D, Adaro M, Barberis S, Vega AE. Antimicrobial Effect of a Proteolytic Enzyme From the Fruits of Solanum granuloso-leprosum (Dunal) Against Helicobacter pylori. Front Nutr 2021;8:699955. [PMID: 34977105 DOI: 10.3389/fnut.2021.699955] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 张 碧. Significance of Helicobacter pylori and Its Serological Typing in Gastric Cancer. ACM 2022;12:11694-11702. [DOI: 10.12677/acm.2022.12121685] [Reference Citation Analysis]
14 Cheok YY, Lee CYQ, Cheong HC, Vadivelu J, Looi CY, Abdullah S, Wong WF. An Overview of Helicobacter pylori Survival Tactics in the Hostile Human Stomach Environment. Microorganisms 2021;9:2502. [PMID: 34946105 DOI: 10.3390/microorganisms9122502] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
15 Ravi GN, Navabshan I, Unnikrishnan S, Ramalingam K. In Silico Protein-Protein Interaction of Pterois volitans Venom with Cancer Inducers of Helicobacter pylori. Appl Biochem Biotechnol 2021. [PMID: 34843077 DOI: 10.1007/s12010-021-03763-x] [Reference Citation Analysis]
16 Naik P, Pandey S, Gagan S, Biswas S, Joseph J. Virulence factors in multidrug (MDR) and Pan-drug resistant (XDR) Pseudomonas aeruginosa: a cross-sectional study of isolates recovered from ocular infections in a high-incidence setting in southern India. J Ophthalmic Inflamm Infect 2021;11:36. [PMID: 34585284 DOI: 10.1186/s12348-021-00268-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Abdi E, Latifi-Navid S, Abedi Sarvestani F, Esmailnejad MH. Emerging therapeutic targets for gastric cancer from a host-Helicobacter pylori interaction perspective. Expert Opin Ther Targets 2021;25:685-99. [PMID: 34410200 DOI: 10.1080/14728222.2021.1971195] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Aydın EM, Demir TD, Seymen N, Said SS, Oktem-Okullu S, Tiftikci A, Cicek B, Tokat F, Tozun N, Ince U, Sezerman U, Sayi-Yazgan A. The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer. Immunol Lett 2021;239:1-11. [PMID: 34363898 DOI: 10.1016/j.imlet.2021.06.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 Grahl MVC, Uberti AF, Broll V, Bacaicoa-Caruso P, Meirelles EF, Carlini CR. Proteus mirabilis Urease: Unsuspected Non-Enzymatic Properties Relevant to Pathogenicity. Int J Mol Sci 2021;22:7205. [PMID: 34281258 DOI: 10.3390/ijms22137205] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Krzyżek P, Migdał P, Paluch E, Karwańska M, Wieliczko A, Gościniak G. Myricetin as an Antivirulence Compound Interfering with a Morphological Transformation into Coccoid Forms and Potentiating Activity of Antibiotics against Helicobacter pylori. Int J Mol Sci 2021;22:2695. [PMID: 33800082 DOI: 10.3390/ijms22052695] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
21 Piscione M, Mazzone M, Di Marcantonio MC, Muraro R, Mincione G. Eradication of Helicobacter pylori and Gastric Cancer: A Controversial Relationship. Front Microbiol 2021;12:630852. [PMID: 33613500 DOI: 10.3389/fmicb.2021.630852] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
22 杨 慧. Study on the Relationship between Helicobacter pylori Associated Gastropathy and HP Genotyping in Qinghai Province. ACM 2021;11:2891-2899. [DOI: 10.12677/acm.2021.116419] [Reference Citation Analysis]
23 Baj J, Forma A, Sitarz M, Portincasa P, Garruti G, Krasowska D, Maciejewski R. Helicobacter pylori Virulence Factors-Mechanisms of Bacterial Pathogenicity in the Gastric Microenvironment. Cells 2020;10:E27. [PMID: 33375694 DOI: 10.3390/cells10010027] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 17.0] [Reference Citation Analysis]
24 Muzaheed. Helicobacter pylori Oncogenicity: Mechanism, Prevention, and Risk Factors. ScientificWorldJournal 2020;2020:3018326. [PMID: 32765194 DOI: 10.1155/2020/3018326] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
25 Hara H, Ozawa S, Ninomiya Y, Yamamoto M, Ogimi M, Nabeshima K, Nakamura K, Kajiwara H, Nakamura N, Sato Y. Prognostic significance of vasohibin-1 and vasohibin-2 immunohistochemical expression in gastric cancer. Surg Today 2020;50:1530-43. [PMID: 32494966 DOI: 10.1007/s00595-020-02040-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
26 Baj J, Korona-Głowniak I, Forma A, Maani A, Sitarz E, Rahnama-Hezavah M, Radzikowska E, Portincasa P. Mechanisms of the Epithelial-Mesenchymal Transition and Tumor Microenvironment in Helicobacter pylori-Induced Gastric Cancer. Cells 2020;9:E1055. [PMID: 32340207 DOI: 10.3390/cells9041055] [Cited by in Crossref: 52] [Cited by in F6Publishing: 57] [Article Influence: 17.3] [Reference Citation Analysis]
27 Zarzecka U, Harrer A, Zawilak-Pawlik A, Skorko-Glonek J, Backert S. Chaperone activity of serine protease HtrA of Helicobacter pylori as a crucial survival factor under stress conditions. Cell Commun Signal 2019;17:161. [PMID: 31796064 DOI: 10.1186/s12964-019-0481-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
28 Ansari S, Yamaoka Y. Helicobacter pylori Virulence Factors Exploiting Gastric Colonization and its Pathogenicity. Toxins (Basel). 2019;11. [PMID: 31752394 DOI: 10.3390/toxins11110677] [Cited by in Crossref: 75] [Cited by in F6Publishing: 81] [Article Influence: 18.8] [Reference Citation Analysis]
29 Maier R, Benoit S. Role of Nickel in Microbial Pathogenesis. Inorganics 2019;7:80. [DOI: 10.3390/inorganics7070080] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
30 Valenzuela-Valderrama M, Cerda-Opazo P, Backert S, González MF, Carrasco-Véliz N, Jorquera-Cordero C, Wehinger S, Canales J, Bravo D, Quest AFG. The Helicobacter pylori Urease Virulence Factor Is Required for the Induction of Hypoxia-Induced Factor-1α in Gastric Cells. Cancers (Basel) 2019;11:E799. [PMID: 31185594 DOI: 10.3390/cancers11060799] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
31 de Jesus Souza M, de Moraes JA, Da Silva VN, Helal-Neto E, Uberti AF, Scopel-Guerra A, Olivera-Severo D, Carlini CR, Barja-Fidalgo C. Helicobacter pylori urease induces pro-inflammatory effects and differentiation of human endothelial cells: Cellular and molecular mechanism. Helicobacter 2019;24:e12573. [PMID: 30907046 DOI: 10.1111/hel.12573] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
32 del Rio B, Redruello B, Fernandez M, Martin MC, Ladero V, Alvarez MA. Lactic Acid Bacteria as a Live Delivery System for the in situ Production of Nanobodies in the Human Gastrointestinal Tract. Front Microbiol 2019;9:3179. [DOI: 10.3389/fmicb.2018.03179] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
33 Liu Y, Zhu J, Ma X, Han S, Xiao D, Jia Y, Wang Y. ceRNA network construction and comparison of gastric cancer with or without Helicobacter pylori infection. J Cell Physiol 2019;234:7128-40. [DOI: 10.1002/jcp.27467] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
34 Schmalstig AA, Benoit SL, Misra SK, Sharp JS, Maier RJ. Noncatalytic Antioxidant Role for Helicobacter pylori Urease. J Bacteriol 2018;200:e00124-18. [PMID: 29866802 DOI: 10.1128/JB.00124-18] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
35 Ansari S, Yamaoka Y. Current understanding and management of Helicobacter pylori infection: an updated appraisal. F1000Res. 2018;7. [PMID: 29946428 DOI: 10.12688/f1000research.14149.1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
36 Kappaun K, Piovesan AR, Carlini CR, Ligabue-Braun R. Ureases: Historical aspects, catalytic, and non-catalytic properties - A review. J Adv Res 2018;13:3-17. [PMID: 30094078 DOI: 10.1016/j.jare.2018.05.010] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 15.6] [Reference Citation Analysis]
37 Scopel-Guerra A, Olivera-Severo D, Staniscuaski F, Uberti AF, Callai-Silva N, Jaeger N, Porto BN, Carlini CR. The Impact of Helicobacter pylori Urease upon Platelets and Consequent Contributions to Inflammation. Front Microbiol 2017;8:2447. [PMID: 29312166 DOI: 10.3389/fmicb.2017.02447] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]